Study of autoantibody against to cyclin-dependent kinase inhibitor-2A (p16) and p90 as tumor marker in human lung cancer by ELISA
碩士 === 中山醫學大學 === 生化暨生物科技研究所 === 94 === The malignant tumour is a main reason to cause the national death, the incidence of the lung cancer is the first of cancers. Nearly 7,000 people die of the lung cancer every year in Taiwan. The first-selected treatment method of the lung cancer is excising wit...
Main Authors: | Shian-Yi, 邱顯益 |
---|---|
Other Authors: | 陳凌雲 |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/20718628022522602932 |
Similar Items
-
Study of autoantibody against to p90, p16 and IMP1 as tumor markers in human esophageal cancer by ELISA
by: Yea-Huey, et al.
Published: (2007) -
Concomitant Presence of p16/Cyclin-dependent Kinase 4 and Cyclin D/Cyclin-dependent Kinase 4 Complexes in LNCaP Prostatic Cancer Cell Line.
by: Ito, Noriyuki
Published: (2011) -
The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
by: Bayrak Aykut, et al.
Published: (2003-05-01) -
Structure of the cyclin-dependent kinase inhibitor p19^INK⁴^d
by: Luh, Frederick Yatlin
Published: (1998) -
Regulation of the cyclin-dependent kinase inhibitor p21 by TBX3
by: Hare, Shannagh
Published: (2014)